Martine Rothblatt
2016
In 2016, Martine Rothblatt earned a total compensation of $15.4M as Chairman and Chief Executive Officer at United Therapeutics, a 580% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $611,425 |
|---|---|
| Non-Equity Incentive Plan | $992,464 |
| Option Awards | $12,583,891 |
| Salary | $1,226,949 |
| Other | $9,600 |
| Total | $15,424,329 |
Rothblatt received $12.6M in option awards, accounting for 82% of the total pay in 2016.
Rothblatt also received $611.4K of change in pension value and nonqualified deferred compensation earnings, $992.5K in non-equity incentive plan, $1.2M in salary and $9.6K in other compensation.
Rankings
In 2016, Martine Rothblatt's compensation ranked 224th out of 14,075 executives tracked by ExecPay. In other words, Rothblatt earned more than 98.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 224 out of 14,075 | 98th |
Division Manufacturing | 72 out of 5,489 | 99th |
Major group Chemicals And Allied Products | 20 out of 1,895 | 99th |
Industry group Drugs | 17 out of 1,538 | 99th |
Industry Pharmaceutical Preparations | 15 out of 1,176 | 99th |
Source: SEC filing on April 28, 2017.
Rothblatt's colleagues
We found five more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2016.
2016
Roger Jeffs
United Therapeutics
Chief Executive Officer
2016
Paul Mahon
United Therapeutics
General Counsel
2016
Michael Benkowitz
United Therapeutics
Chief Operating Officer
2016
James Edgemond
United Therapeutics
Chief Financial Officer
2016
David Zaccardelli
United Therapeutics